Limba
|
CDKI-73 (LS-007) is a potent CDKinhibitor in vitro with IC50 of 8.17 nM, 3.27 nM, 8.18 nM, and 5.78 nM for CDK1, CDK2, CDK4, and CDK9, respectively. CDKI-73 induces apoptosis in cancer cells. CDKI-73 is an orally bioavailable and highly efficacious CDK9inhibitor against acute myeloid leukemia.
Price | 2.505,00 RON (preturile sunt fara TVA) |
---|---|
Description |
CDKI-73 (LS-007) is a potent CDKinhibitor in vitro with IC50 of 8.17 nM, 3.27 nM, 8.18 nM, and 5.78 nM for CDK1, CDK2, CDK4, and CDK9, respectively. CDKI-73 induces apoptosis in cancer cells. CDKI-73 is an orally bioavailable and highly efficacious CDK9inhibitor against acute myeloid leukemia. |